US stock futures are staying relatively stable in Tuesday's premarket session as investors anticipate significant inflation data set to be released on Wednesday morning, which includes both monthly and weekly consumer price index figures as well as core CPI readings. Futures for the Dow Jones Industrial Average dipped by 0.1%, while S&P 500 futures saw a slight increase of 0.08%.
Meanwhile, Nasdaq futures climbed by 0.2%. In the oil market, prices are trending down, with front-month global benchmarks, North Sea Brent crude, showing a decrease of 0.3% to settle at $71.94 per barrel, and US West Texas Intermediate crude also down by 0.3%, priced at $68.18 per barrel. In the equities sector, shares of Chimerix ($CMRX) skyrocketed by 198% in Tuesday's premarket session after the biotech company announced that it plans to submit a New Drug Application to the US Food and Drug Administration before year-end, seeking accelerated approval for dordaviprone, a treatment for recurrent H3 K27M-mutant diffuse glioma.
Additionally, Cumberland Pharmaceuticals ($CPIX) experienced a remarkable 130% surge after stating on Tuesday that the FDA approved a supplemental NDA for acetadote, a drug aimed at preventing or mitigating liver injury following high doses of acetaminophen. Shares of Interactive Strength ($TRNR) also saw impressive gains, rising by 27% after announcing it has regained compliance with Nasdaq's minimum bid price rule. Conversely, Biora Therapeutics ($BIOR) suffered a significant drop, tumbling 46% after it disclosed in a regulatory filing that it would be delisted from Nasdaq due to non-compliance with the minimum market value of listed securities requirement, effective Wednesday.
Similarly, MEDIROM Healthcare Technologies ($MRM) shares fell by 39% following its announcement on Monday to launch a public offering of 2,860,000 American Depositary Shares at $1.75 each, aiming for approximately $5 million in gross proceeds. Additionally, shares of Radiopharm Theranostics (RADX) dropped 23%, continuing its downturn from Monday when it lost 51%..